The Use of Dorzolamide and Pilocarpine as Adjunctive Therapy to Timolol in Patients with Elevated Intraocular Pressure
- 1 August 1996
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 103 (8) , 1283-1293
- https://doi.org/10.1016/s0161-6420(96)30509-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A Six-week Dose-response Study of the Ocular Hypotensive Effect of Dorzolamide With a One-year ExtensionAmerican Journal of Ophthalmology, 1996
- A Double-Masked, Randomized 1-Year Study Comparing Dorzolamide (Trusopt), Timolol, and BetaxololArchives of Ophthalmology (1950), 1995
- Four-Week Safety and Efficacy Study of Dorzolamide, a Novel, Active Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1993
- Dose Response and Duration of Action of Dorzolamide, a Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1992
- MK-507 (L-671,152), a Topically Active Carbonic Anhydrase Inhibitor, Reduces Aqueous Humor Production in MonkeysArchives of Ophthalmology (1950), 1991
- MK-507 versus SezolamideOphthalmology, 1991
- A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animalsCurrent Eye Research, 1990
- Efficacy of combining timolol with other antiglaucoma medicationsSurvey of Ophthalmology, 1983
- Separate and Combined Effects of Timolol Maleate and Acetazolamide in Open-Angle GlaucomaAmerican Journal of Ophthalmology, 1981
- Carbonic Anhydrase Inhibitor Side EffectsArchives of Ophthalmology (1950), 1977